Professional & Business

  • International Medical Press

Obesity rates rise as adolescence approaches

  • International Medical Press

HEE launches ‘Cancer Workforce Plan for England’

  • International Medical Press

One-fifth of GP appointments in Scotland are ‘no-shows’

  • International Medical Press

Add folic acid to flour, urge health ministers

  • International Medical Press

Scarfs protect against asthma attacks, charity says

  • International Medical Press

‘Dangerous’ diet pills bypassing health system

View more

New in Gynaecology

  • Global Clinical Summaries from Cliin Infect Dis
  • 1 comment

HIV: data confirm long-term benefits of early cART

Immediate initiation during primary infection yields sustained clinical benefits.

  • Global Clinical Summaries from MSMR
  • 1 comment

Active duty servicewomen and pregnancy complications

Coding practices make it difficult to accurately identify the most common pregnancy complications.

  • The ASCO Post
  • 1 comment

SABCS 2017: Adjuvant Trastuzumab Did Not Improve Outcomes for Patients With HER2-Low Breast Cancer

Adding trastuzumab to standard adjuvant chemotherapy did not improve invasive disease–free survival for patients with early-stage breast cancer found to have low levels of HER2, according to data from the randomized, phase III NSABP B-47 clinical trial presented by Fehrenbacher et al.

  • Global Clinical Summaries from Am J Obstet Gynecol
  • 1 comment

Who would consider uterus donation or transplantation?

1 in 500 women is affected by absolute uterine-factor infertility.

  • The ASCO Post
  • 1 comment

Increasing the Dose Intensity of Chemotherapy May Lower the Risk of Breast Cancer Recurrence and Death

Increasing the dose intensity of chemotherapy—by either shortening the intervals between the cycles or by sequential administration instead of concurrent administration of the drugs—reduced the risk of early-stage breast cancer recurrence and death compared with standard chemotherapy regimens, according to data from an Early Breast Cancer Trialists' Collaborative Group meta-analysis study presented by Gray et al.

Should patients contribute to their medical records?
  • Global Medical News
  • 1 comment

Should patients contribute to their medical records?

Experts suggest the practice could reduce time spent on documentation and improve doctor-patient relationships.

  • Global Clinical Summaries from Bull World Health Organ
  • 1 comment
  • FULLTEXT

Zika persists in semen for 144 days after infection, symptom onset

Infected men, including those with vasectomy, should be counseled on transmission prevention.

  • Global Clinical Summaries from Matern Child Health J
  • 1 comment
  • FULLTEXT

Prenatal care patterns in women residing along the US-Mexico border

Political issues related to immigration, lack of insurance may be obstacles to healthcare engagement.

  • Global Clinical Summaries from Lancet
  • 1 comment
  • FULLTEXT

Zika vaccine: early data demonstrate safety, immunogenicity

Data from 3 placebo-controlled, randomized phase 1 trials.

  • Global Clinical Summaries from Pregnancy Hypertens
  • 1 comment

Is pregnancy a stress test for chronic disease?

Metabolic stress during pregnancy may result in vascular damage that contributes to CV, renal disease.

DNR tattoo poses ethical dilemma for doctors
  • Global Medical News
  • 1 comment

DNR tattoo poses ethical dilemma for doctors

Doctors at a US hospital were recently tasked with deciding whether or not to honour a 'Do Not Resuscitate' request tattoed on a patient.

  • Univadis Editorial - Dr Harry Brown
  • 1 comment

Going high tech

Saving valuable clinical time with voice recognition technology

Guy's and St Thomas' research unit receives MHRA accreditation
  • UK Medical News
  • 1 comment

Guy's and St Thomas' research unit receives MHRA accreditation

Guy's and St Thomas' NHS Foundation Trust has become the first NHS-managed facility in London to be granted phase I accreditation.

  • Global Clinical Summaries from Acta Obstet Gynecol Scand
  • 1 comment

LEEP, not CIN I, associated with preterm birth

Delay treatment of CIN I with LEEP, especially in young women.